中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
o-甲酚-d7 |
(2)H7-o-cresol |
202325-50-6 |
C7H8O |
|
o-甲酚-d3(甲基-d3) |
2-<(D3)methyl>phenol |
70837-27-3 |
C7H8O |
|
o-甲苯酚酸钠 |
(4-chloro-2-sulfamoylphenoxy)-acetic acid |
4486-75-3 |
C8H8ClNO5S |
|
o-甲苯甲酰-5-羟基奥美拉唑 |
o-Toluoyl-5-hydroxy Omeprazole |
120003-79-4 |
C25H25N3O5S |
|
o-氧化甲氧基苯胺 |
N,N'-bis<(2-methoxy)phenyl>oxamide |
21021-99-8 |
C16H16N2O4 |
|
o-异壬基苯酚 |
methylmalonyl-CoA |
73173-91-8 |
C25H40N7O19P3S |
|
o-仲-丁基-α,α,&#x3B2,&#x3B2-四氟苯乙醚 |
1,4,5,8-tetrakis-cyclohexylamino-anthraquinone |
28634-38-0 |
C38H52N4O2 |
|
o-[[[2-[[2-(1,3-二氢-1,3-二羰基-2H-异吲哚-2-基)乙基](羟甲基)氨基]乙基]氨基]羰基]苯甲酸,混合物和2,2'-亚氨基二乙醇(1:1) |
Einecs 309-228-8 |
100145-55-9 |
C25H32N4O8 |
|
o-[[1-羟基-6-[[[[2-甲氧基-5-甲基-4-[[8-[(苯基磺基基)氧代]-3,6-二磺基-1-萘基]偶氮]苯基]氨基]羰基]氨基]-3-磺基-2-萘基]偶氮]苯甲酸,钠盐 |
1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N,2-dimethylpropan-2-amine;hydron;chloride |
—— |
C17H26ClN |
|
o-[1-(1,4-二甲氧基-2-萘基)乙基]苯甲酸 |
o-<1-(1,4-dimethoxy-2-naphthyl)ethyl>benzoic acid |
102235-11-0 |
C21H20O4 |
|
o-[1-(1,4-二甲氧基-2-萘基)乙基]苯基甲基甲醇 |
o-<1-(1,4-dimethoxy-2-naphthyl)ethyl>phenylmethylcarbinol |
102235-13-2 |
C22H24O3 |
|
o-[(甲硫基)甲基]苯酚 |
o-(methylthiomethyl)-phenol |
4526-41-4 |
C8H10OS |
|
o-[(4-甲氧基苯基)甲基]s-硫代羧酸苯酯 |
Carbonothioic acid, O-((4-methoxyphenyl)methyl) S-phenyl ester |
62778-21-6 |
C15H14O3S |
|
o-1,5-薄荷二烯 |
o-1,5-menthadiene |
527-83-3 |
C10H16 |
|
o-(环丙基甲氧基)苯酚 |
2-(cyclopropylmethoxy)phenol |
25947-69-7 |
C10H12O2 |
|
o-(己氧基)碳杂酰苯胺酸1-乙基-4-哌啶基酯盐酸 |
(1-Ethylpiperidin-1-ium-4-yl)n-(2-hexoxyphenyl)carbamate chloride |
105383-98-0 |
C20H33ClN2O3 |
|
o-(4-羟基苯基)-3,5-二碘-L-酪氨酸甲酯 |
3,5-diiodo-L-thyronine methyl ester |
203585-45-9 |
C16H15I2NO4 |
|
o-(1-氨基-1-甲基乙基)苯酚 |
o-(1-amino-1-methylethyl)phenol |
117343-33-6 |
C9H13NO |
|
o,p-二甲苯 |
Phenyl-phosphonic acid bis-(2,5-dichloro-phenyl) ester |
71432-26-3 |
C18H11Cl4O3P |
|
o,p'-甲氧滴滴涕 |
1,1,1-trichloro-2-(2-methoxyphenyl)-2-(4-methoxyphenyl)ethane |
30667-99-3 |
C16H15Cl3O2 |
|
[[O-(烯丙氧基)苯氧基]甲基]环氧乙烷 |
1-(2-allyloxyphenoxy)-2,3-epoxypropane |
6452-72-8 |
C12H14O3 |
|
O,α-二甲基-L-酪氨酸盐酸盐 |
(2S)-2-amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride |
35026-10-9 |
C11H15NO3*ClH |
|
O,O’-二乙基-(2-琥珀酸二乙酯基)膦酸酯 |
diethyl 2-(diethoxyphosphoryl)succinate |
7071-15-0 |
C12H23O7P |
|
O型304 |
4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide |
1261289-04-6 |
C16H11Cl2N3O2S |
|
Ox吲哚-4-硼酸频那醇酯 |
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one |
1150271-44-5 |
C14H18BNO3 |
|
OtBu-L-谷氨酸甲酯盐酸盐 |
L-glutamic acid 5-tert-butyl 1-methyl ester hydrochloride |
6234-01-1 |
C10H19NO4*ClH |
|
Orteronel; 6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-c]咪唑-7-基]-N-甲基-2-萘甲酰胺 |
Orteronel |
566939-85-3 |
C18H17N3O2 |
|
Org24598锂盐;R-(-)-N-甲基-N-[(3R)-3-苯基-3-[4-(三氟甲基)苯氧基]丙基]甘氨酸锂 |
Org 24598 lithium salt |
722456-08-8 |
C19H19F3LiNO3 |
|
Oprozomib(ONX-0912)抑制剂 |
oprozomib |
935888-69-0 |
C25H32N4O7S |
|
Oplopanone; 10alpha-羟基日本刺参萜-4-酮 |
oplopanone |
1911-78-0 |
C15H26O2 |
|
Oplodiol; (1S,4R,4aR,8aR)-1,2,3,4,4a,5,8,8a-八氢-1,4a-二甲基-7-(1-甲基乙基)-1,4-二羟基萘 |
1β,4β-dihydroxy-trans-eudesm-7-ene |
13902-62-0 |
C15H26O2 |
|
Ono-4007单钠盐 |
Ono-4007 sodium salt |
152646-95-2 |
C50H78NNaO12S |
|
Omi/HtrA2蛋白酶抑制剂,Ucf-101 |
High Temperature Requirement A2 Inhibitor I |
313649-08-0 |
C27H17N3O5S |
|
Oleoside; (2S,3E,4S)-5-羧基-3-亚乙基-2-(beta-D-吡喃葡萄糖氧基)-3,4-二氢-2H-吡喃-4-乙酸 |
oleoside |
178600-68-5 |
C16H22O11 |
|
Olcegepant; N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺 |
Olcegepant |
204697-65-4 |
C38H47Br2N9O5 |
|
Odoratone;22,25-环氧-23,24-二羟基-13alpha,14beta,17betaH-羊毛甾-7-烯-3-酮 |
Odoratone |
16962-90-6 |
C30H48O4 |
|
Odanacatib中间体 |
ethyl 2-amino-4-methylpent-4-enoate |
68843-73-2 |
C8H15NO2 |
|
Octahydroazocine盐酸盐 |
azocane hydrochloride |
36520-41-9 |
C7H15N*ClH |
|
Oblongine;(S)-1,2,3,4-四氢-8-羟基-1-[(4-羟基苯基)甲基]-7-甲氧基-2,2-二甲基异喹啉 |
(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol |
60008-01-7 |
C19H24NO3+ |
|
Obatoclax甲磺酸盐 |
Obatoclax mesylate |
803712-79-0 |
C21H23N3O4S |
|
OZANIMOD中间体 |
(R)-tert-butyl 4-cyano-2,3-dihydro-1H-inden-1-ylcarbamate |
1306763-30-3 |
C15H18N2O2 |
|
OZ439标准品 |
4-(2-(4-(dispiro[adamantane-2,3'-[1,2,4]trioxolane-5',1''-cyclohexan]-4''-yl)phenoxy)ethyl)morpholine |
1029939-86-3 |
C28H39NO5 |
|
OTSSP167盐酸盐 |
OTSSP167 hydrochloride |
1431698-10-0 |
C25H29Cl3N4O2 |
|
OSI-027; 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-f][1,2,4]三嗪-7-基]环己烷羧酸 |
OSI-027 |
936890-98-1 |
C21H22N6O3 |
|
OSI 420; 2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧]乙醇盐酸盐 |
2-[4-(3-Ethynyl-phenylamino)-7-(2-methoxy-ethoxy)-quinazolin-6-yloxy]-ethanol hydrochloride |
183320-51-6 |
C21H21N3O4*ClH |
|
ORL1拮抗剂1 |
ORL1 antagonist 1 |
1174985-59-1 |
C20H22ClN5 |
|
OPC-920257中间体 |
L-leucyl-L-phenylalanine methyl ester |
38155-18-9 |
C16H24N2O3 |
|
OO-叔-丁基 O-环己基过氧碳酸酯 |
percarbonate de O,O-t-butyl et O-cyclohexyl |
21690-93-7 |
C11H20O4 |
|
ONX-0914(PR-957)抑制剂 |
Onx-0914 (PR-957) |
960374-59-8 |
C31H40N4O7 |
|
ONO 8711; (5Z)-6-[(2R,3S)-3-[[[(4-氯-2-甲基苯基)磺酰基]氨基]甲基]双环[2.2.2]辛-2-基]-5-己烯酸 |
6-[(2R,3S)-3-[[[(4-chloro-2-methylphenyl)sulfonyl]amino]methyl]bicyclo[2.2.2]oct-2-yl]-5Z-hexenoic acid |
216158-34-8 |
C22H30ClNO4S |
|